CLINICAL_TRIALS
trial_result
· 2014-08-05
Clinical Trial Update: Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder [Phase 3]
Summary
Phase 3 study evaluating vortioxetine for cognitive dysfunction in adults with major depressive disorder; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-08-05